- BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
- BioLife Solutions Reports First Quarter 2024 Financial Results
- BioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business
Key statistics
On Wednesday, BioLife Solutions Inc (BJX1:STU) closed at 18.60, -11.43% below its 52-week high of 21.00, set on May 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.60 |
---|---|
High | 18.60 |
Low | 18.60 |
Bid | 17.50 |
Offer | 19.70 |
Previous close | 19.30 |
Average volume | 0.00 |
---|---|
Shares outstanding | 46.07m |
Free float | 44.71m |
P/E (TTM) | -- |
Market cap | 931.97m USD |
EPS (TTM) | -1.43 USD |
Data delayed at least 15 minutes, as of Jul 03 2024.
More ▼